Hogan Lovells Our thinking banner

Our thinking

Discover insights, analysis, and thought leadership that are vital for change. Success today requires actionable insights, perspectives that cut through complexity, and tools to navigate the evolving needs of your sector shaping a stronger tomorrow.

Back to Our thinking

English
中文
Deutsch
Español
Français
日本語
Português

News

US president’s working group issues report outlining key policy recommendations for digital assets regulation

18 August 2025

News

FDA updates medical device user fee guidance for small businesses, tightening some rules for reductions and waivers

15 August 2025

Insights and Analysis

Art, sanctions and suspicion: What the Ojiri case tells us about risk and responsibility in the regulated sector

11 August 2025

News

U.S. de minimis customs exception to end in August 2025

08 August 2025

News

EU’s 18th sanctions package takes aim at investor-State dispute settlement: another layer to the EU’s sanctions toolkit

08 August 2025

News

Key takeaways – UK MHRA’s response to consultation on ‘Medical Devices Regulations: Routes to market and in vitro diagnostic devices’

05 August 2025

Insights and Analysis

“New NEPA”

05 August 2025

News

ESG Focus: UK/EU/International ESG regulation monthly round-up – July 2025

04 August 2025

News

Pharmacy compounding under the EU pharma law package

01 August 2025

Insights and Analysis

EFRAG launch consultation on simplified European Sustainability Reporting Standards (ESRS) under the Corporate Sustainability Reporting Directive (CSRD)

01 August 2025

News

SEC staff updates guidance on Section 13 beneficial ownership reporting rules

31 July 2025

Insights and Analysis

Turnaround of Medical Cannabis in Germany? – Draft bill by new German Government to address alleged missteps

31 July 2025

Load more

Digital Client Solutions

Empowering you to lead change through our digital solutions.